Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment
2009
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Management of hepatitis B
2007
Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer
2002
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Salivary analysis of oral cancer biomarkers
2009
EGFR Antagonists in Cancer Treatment
2008 Standout
The Clinical Spectrum of Hepatitis C Virus in HIV Coinfection
2003
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV
2004
Impact of highly active antiretroviral therapy on the spectrum of liver disease in hcv-hiv coinfection
2004
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
2008
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
2004
Liver Transplantation in Hiv-Infected Recipients
2005
Metronomic therapy for breast cancer
2004
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients
2004
Hepatitis C Virus in the HIV-Infected Patient
2006
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Changing Spectrum of Mortality Due to Human Immunodeficiency Virus: Analysis of 260 Deaths during 1995-1999
2001
Head and neck cancer
2008 Standout
Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons
2004
Hepatitis B virus infection
2009 Standout
Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons
2006
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
2005
Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART)
2008
Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer
2001
The molecular biology of head and neck cancer
2010 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Effect of Human Immunodeficiency Virus and Antiretrovirals on Outcomes of Hepatitis C: A Systematic Review From an Epidemiologic Perspective
2007
Trends in Diseases Reported on U.S. Death Certificates That Mentioned HIV Infection, 1987–1999
2002
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Role of Liver Biopsy in the Evaluation of Hepatitis C Virus Infection in HIV Coinfection
2005
Zidovudine use but not weight‐based ribavirin dosing impacts anaemia during HCV treatment in HIV‐infected persons
2006
Solid-Organ Transplantation in HIV-Infected Patients
2002
Hepatitis C advances in antiviral therapy: What is accepted treatment now?
2002
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
2008
Liver transplantation in patients with HIV infection
2004
Treatment of hepatitis C
2005
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus†
2009
Phase II study of weekly docetaxel in patients with metastatic breast cancer
2002
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
2001
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
Tenofovir Disoproxil Fumarate Therapy for Chronic Hepatitis B in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Individuals for Whom Interferon‐α and Lamivudine Therapy Have Failed
2002
Treatment of Chronic HCV Infection in Special Populations
2006
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Regulation of Vascularization by Hypoxia‐Inducible Factor 1
2009 StandoutNobel
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
2003
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
2002
Infection in Solid-Organ Transplant Recipients
2007 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Causes of death among HIV‐infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998–1999
2002
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Efficacy of Tenofovir Disoproxil Fumarate in Antiretroviral Therapy–Naive and –Experienced Patients Coinfected with HIV‐1 and Hepatitis B Virus
2004
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma
2001
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection
2005
Replication of hepatitis C virus
2007 StandoutNobel
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)
2003
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
2006
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata
2003
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Hepatitis C in the HIV-Infected Person
2003
Causes of Death among Persons with AIDS in the Era of Highly Active Antiretroviral Therapy: New York City
2006
Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
2009
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
NCCN Task Force Report: Management of Neuropathy in Cancer
2009
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Assessment of Tumor Necrosis Factor Alpha Blockade As an Intervention to Improve Tolerability of Dose-Intensive Chemotherapy in Cancer Patients
2006
Review of solid-organ transplantation in HIV-infected patients
2003
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Development of novel treatments for hepatitis C
2009
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.
2002
The immunoregulatory effects of antidepressants
2001
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Rochelle Scheib being referenced
Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection
2001
In vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIV seropositive male homosexuals with AIDS-related complex
1987
Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment
2008
Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer
2000